ArticlePlastic and reconstructive surgery. Global open2026
The Use of Hemostatic Agents to Decrease Surgical Drain Time in General Plastic Surgery Procedures.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Drains can be used in general plastic surgery procedures given the extensive undermining of tissue. Our primary goal was to investigate whether hemostatic agents used during general plastic surgery procedures could decrease drain time length. Secondary goals were to investigate whether hemostatic agents decreased seromas and hematomas. Methods: A retrospective chart review was conducted including patients undergoing bilateral breast reduction (BBR), abdominoplasty, or panniculectomy. Data collected included use of hemostatic agent (fibrin sealant [EVICEL] or combination powder [HEMOBLAST Bellows]), time to surgical drain removal, and postoperative complications (seroma, hematoma, and operative reintervention). Statistical analyses included Results: A total of 351 patients were included. For both the abdominoplasty/panniculectomy and BBR groups, there were statistically significant reductions in surgical drain duration with combination powder compared with no hemostatic agent-13.5 versus 27.9 days for abdominoplasty/panniculectomy ( Conclusions: The use of hemostatic agents such as fibrin sealant or combination powder in general plastic surgery procedures is associated with a statistically significant reduction in postoperative surgical drain duration.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.